Application of next generation sequencing to molecular diagnosis of inherited diseases

Topics in Current Chemistry

Volumn 336, Issue , 2014, Pages 19-46

  Zhang, Wei ^a   Cui, Hong ^a   Wong, Lee Jun C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Human genetic diseases; Massively parallel sequencing (MPS); Molecular diagnosis; Next generation sequencing (NGS); Target gene enrichment

Indexed keywords

EXOME; GENETIC DISORDER; HETEROZYGOTE DETECTION; HIGH THROUGHPUT SEQUENCING; HUMAN; METHODOLOGY; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REVIEW;

EXOME; GENETIC DISEASES, INBORN; HETEROZYGOTE DETECTION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS;

EID: 84890903146     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128-2012-325     Document Type: Review

References (116)

1. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74(12):5463-5467
2. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong S-E et al (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134(1):112-123
3. Calvo S, Jain M, Xie X, Sheth SA, Chang B, Goldberger OA et al (2006) Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38(5):576-582
4. Thorburn D (2004) Mitochondrial disorders: Prevalence, myths and advances. J Inherit Metab Dis 27(3):349-362
5. Scharfe C, Lu HH-S, Neuenburg JK, Allen EA, Li G-C, Klopstock T et al (2009) Mapping gene associations in human mitochondria using clinical disease phenotypes. PLoS Comput Biol 5(4):e1000374
6. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP et al (2007) The diploid genome sequence of an individual human. PLoS Biol 5(10):e254
7. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, Mcguire A et al (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452 (7189):872-876
8. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE et al (2010) Clinical assessment incorporating a personal genome. Lancet 375(9725):1525-1535
9. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DCY, Nazareth L et al (2010) Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 362(13):1181-1191
10. Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ et al (2011) Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet 7(9):e1002280
11. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I et al (2011) Whole-genome sequencing for optimized patient management. Sci Transl Med 3(87):87re3
12. 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061-1073
13. Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 9(1):387-402
14. Metzker ML (2010) Sequencing technologies - The next generation. Nat Rev Genet 11 (1):31-46
15. Shendure J, Ji H (2008) Next-generation DNA sequencing. Nat Biotechnol 26 (10):1135-1145
16. Gibbs RA (2011) Bringing genomics and genetics back together. Science 331(6017):548
17. Collins FS (2011) Faces of the genome. Science 331(6017):546
18. Green ED, Guyer MS (2011) Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333):204-213
19. Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470 (7333):187-197
20. Voelkerding KV, Dames SA, Durtschi JD (2009) Next-generation sequencing: From basic research to diagnostics. Clin Chem 55(4):641-658
21. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA et al (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 (7057):376-380
22. Bennett S (2004) Solexa Ltd. Pharmacogenomics 5(4):433-438
23. Bennett ST, Barnes C, Cox A, Davies L, Brown C (2005) Toward the $1000 human genome. Pharmacogenomics 6(4):373-382
24. Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP, Rosenbaum AM et al (2005) Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309 (5741):1728-1732
25. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M et al (2011) An integrated semiconductor device enabling non-optical genome sequencing. Nature 475 (7356):348-352
26. Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, Braslavsky I et al (2008) Singlemolecule DNA sequencing of a viral genome. Science 320(5872):106-109
27. Korlach J, Bjornson KP, Chaudhuri BP, Cicero RL, Flusberg BA, Gray JJ et al (2010) Chapter 20: Real-time DNA sequencing from single polymerase molecules. Methods in Enzymology. Academic, pp 431-455
28. Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA et al (2010) Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods 7(6):461-465
29. Turner EH, Ng SB, Nickerson DA, Shendure J (2009) Methods for genomic partitioning. Annu Rev Genomics Hum Genet 10(1):263-284
30. Ng SB, Nickerson DA, Bamshad MJ, Shendure J (2010) Massively parallel sequencing and rare disease. Hum Mol Genet 19(R2):R119-R124
31. Lu C, Tej SS, Luo S, Haudenschild CD, Meyers BC, Green PJ (2005) Elucidation of the small RNA component of the transcriptome. Science 309(5740):1567-1569
32. Axtell MJ, Jan C, Rajagopalan R, Bartel DP (2006) A two-hit trigger for siRNA biogenesis in plants. Cell 127(3):565-577
33. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu A-L et al (2008) Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18(4):610-621
34. Martin JA, Wang Z (2011) Next-generation transcriptome assembly. Nat Rev Genet 12 (10):671-682
35. Hawkins RD, Hon GC, Ren B (2010) Next-generation genomics: An integrative approach. Nat Rev Genet 11(7):476-486
36. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462 (7271):315-322
37. Hu H, Wrogemann K, Kalscheuer V, Tzschach A, Richard H, Haas SA et al (2009) Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing. Hugo J 3(1-4):41-49
38. Gowrisankar S, Lerner-Ellis JP, Cox S, White ET, Manion M, LeVan K et al (2010) Evaluation of second-generation sequencing of 19 dilated cardiomyopathy genes for clinical applications. J Mol Diagn 12(6):818-827
39. Voelkerding KV, Dames S, Durtschi JD (2010) Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: A paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 12(5):539-551
40. Vasta V, Ng S, Turner E, Shendure J, Hahn SH (2009) Next generation sequence analysis for mitochondrial disorders. Genome Med 1(10):100
41. Lubin IM, Caggana M, Constantin C, Gross SJ, Lyon E, Pagon RA et al (2008) Ordering molecular genetic tests and reporting results: Practices in laboratory and clinical settings. J Mol Diagn 10(5):459-468
42. Maddalena A, Bale S, Das S, Grody W, Richards S, the ALQAC (2005) Technical standards and guidelines: Molecular genetic testing for ultra-rare disorders. Genet Med 7(8):571-583
43. Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD (2009) Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep 58(RR-6):1-37, quiz CE-1-4
44. Vance GH (2011) College of American pathologists proposal for the oversight of laboratorydeveloped tests. Arch Pathol Lab Med 135(11):1432-1435
45. Chou L-S, Liu CSJ, Boese B, Zhang X, Mao R (2010) DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model. Clin Chem 56(1):62-72
46. Baetens M, Van Laer L, De Leeneer K, Hellemans J, De Schrijver J, Van De Voorde H et al (2011) Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys- Dietz syndromes. Hum Mutat 32(9):1053-1062
47. Schlipf NA, Schule R, Klimpe S, Karle KN, Synofzik M, Schicks J et al (2011) Ampliconbased high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients. Clin Genet 80(2):148-160
48. Jones MA, Bhide S, Chin E, Ng BG, Rhodenizer D, Zhang VW et al (2011) Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation. Genet Med 13(11):921-932
49. Simpson DA, Clark GR, Alexander S, Silvestri G, Willoughby CE (2011) Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa. J Med Genet 48(3):145-151
50. Tang S, Huang T (2010) Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. Biotechniques 48(4):287-296
51. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J et al (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra4
52. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al (2009) Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42(1):30-35
53. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI et al (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42(9):790-793
54. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B et al (2011) Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 13(3):255-262
55. Chiu RWK, Sun H, Akolekar R, Clouser C, Lee C, McKernan K et al (2010) Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 56(3):459-463
56. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151 (1):33-40
57. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N et al (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15(6):541-555
58. Judge DP, Dietz HC (2005) Marfan's syndrome. Lancet 366(9501):1965-1976
59. Robinson PN, Arteaga-Solis E, Baldock C, Collod-Baroud G, Booms P, De Paepe A et al (2006) The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43 (10):769-787
60. Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: Clinical features and pathogenetic mechanisms. Lancet Neurol 7(12):1127-1138
61. Zimmerman RS, Cox S, Lakdawala NK, Cirino A, Mancini-DiNardo D, Clark E et al (2010) A novel custom resequencing array for dilated cardiomyopathy. Genet Med 12(5):268-278. doi:10.1097/GIM.0b013e3181d6f7c0
62. Sakai H, Suzuki S, Mizuguchi T, Imoto K, Yamashita Y, Doi H et al (2012) Rapid detection of gene mutations responsible for non-syndromic aortic aneurysm and dissection using two different methods: Resequencing microarray technology and next-generation sequencing. Hum Genet 131(4):591-599
63. Jaeken J, Matthijs G (2007) Congenital disorders of glycosylation: A rapidly expanding disease family. Annu Rev Genomics Hum Genet 8(1):261-278
64. Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL et al (2010) SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 142(2):203-217
65. Ng BG, Sharma V, Sun L, Loh E, Hong W, Tay SKH et al (2011) Identification of the first COG-CDG patient of Indian origin. Mol Genet Metab 102(3):364-367
66. Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F et al (2000) Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat 16 (5):386-394
67. Fishman GA (1978) Retinitis pigmentosa: Visual loss. Arch Ophthalmol 96(7):1185-1188
68. Ropers HH (2008) Genetics of intellectual disability. Curr Opin Genet Dev 18(3):241-250
69. Wong L-JC (2010) Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 16 (2):154-162
70. Huang T (2010) Next generation sequencing to characterize mitochondrial genomic DNA heteroplasmy. Current Protocols in Human Genetics. Wiley
71. Cui H, Zhang W, Wong L-JC (2011) Comprehensive molecular analyses of mitochondrial genome by next-generation sequencing 12th International Congress of Human Genetics/ 61st Annual Meeting of The American Society of Human Genetics; 2011; Montreal, Canada, 2011
72. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N et al (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94(1):16-37
73. Wong L-JC, Scaglia F, Graham BH, Craigen WJ (2010) Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 100(2):111-117
74. Berardo A, DiMauro S, Hirano M (2010) A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep 10(2):118-126
75. DiMauro S, Schon EA (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31(1):91-123
76. Costa T, Scriver CR, Childs B (1985) The effect of Mendelian disease on human health: A measurement. Am J Med Genet 21(2):231-242
77. Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF (2001) Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc 76 (8):777-783
78. Boone P, Wiszniewski W, Lupski J (2011) Genomic medicine and neurological disease. Hum Genet 130(1):103-121
79. Biesecker LG (2010) Exome sequencing makes medical genomics a reality. Nat Genet 42 (1):13-14
80. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076):485-487
81. Rossa WKC, Ranjit A, Yama WLZ, Tak YL, Hao S, Chan KCA et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342:c7401
82. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am J Obstet Gynecol 204(3):205.e1-e11
83. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M et al (2011) DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 13(11):913-920
84. Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, Lun FMF et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2(61):61ra91
85. Ottesen EA, Hong JW, Quake SR, Leadbetter JR (2006) Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 314(5804):1464-1467
86. Spurgeon SL, Jones RC, Ramakrishnan R (2008) High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS One 3(2):e1662
87. Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH et al (2009) Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 27(11):1025-1031
88. Okou DT, Steinberg KM, Middle C, Cutler DJ, Albert TJ, Zwick ME (2007) Microarraybased genomic selection for high-throughput resequencing. Nat Methods 4(11):907-909
89. Okou DT, Locke AE, Steinberg KM, Hagen K, Athri P, Shetty AC et al (2009) Combining microarray-based genomic selection (MGS) with the illumina genome analyzer platform to sequence diploid target regions. Ann Hum Genet 73(5):502-513
90. Clark MJ, Chen R, Lam HYK, Karczewski KJ, Chen R, Euskirchen G et al (2011) Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 29(10):908-914
91. Sulonen A-M, Ellonen P, Almusa H, Lepisto M, Eldfors S, Hannula S et al (2011) Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 12(9):R94
92. Asan, Xu Y, Jiang H, Tyler-Smith C, Xue Y, Jiang T et al (2011) Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 12(9):R95
93. Parla J, Iossifov I, Grabill I, Spector M, Kramer M, McCombie WR (2011) A comparative analysis of exome capture. Genome Biol 12(9):R97
94. Robinson PN, Krawitz P, Mundlos S (2011) Strategies for exome and genome sequence data analysis in disease-gene discovery projects. Clin Genet 80(2):127-132
95. Tucker EJ, Mimaki M, Compton AG, McKenzie M, Ryan MT, Thorburn DR (2012) Nextgeneration sequencing in molecular diagnosis: NUBPL mutations highlight the challenges of variant detection and interpretation. Hum Mutat 33(2):411-418
96. De Leeneer K, De Schrijver J, Clement L, Baetens M, Lefever S, De Keulenaer S et al (2011) Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics. PLoS One 6(9):e25531
97. The International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164):851-861
98. Vissers LELM, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P et al (2010) A de novo paradigm for mental retardation. Nat Genet 42(12):1109-1112
99. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S et al (2011) Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43(6):585-589
100. Lindblom A, Robinson PN (2011) Bioinformatics for human genetics: Promises and challenges. Hum Mutat 32(5):495-500
101. Medvedev P, Stanciu M, BrudnoM(2009) Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 6(11s):S13-S20
102. Wei Q, Wang L, Wang Q, Kruger WD, Dunbrack RL (2010) Testing computational prediction of missense mutation phenotypes: Functional characterization of 204 mutations of human cystathionine beta synthase. Proteins 78(9):2058-2074
103. Roach JC, Glusman G, Smit AFA, Huff CD, Hubley R, Shannon PT et al (2010) Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328 (5978):636-639
104. Robinson P (2010) Whole-exome sequencing for finding de novo mutations in sporadic mental retardation. Genome Biol 11(12):144
105. Ross JS (2011) Next-generation pathology. Am J Clin Pathol 135(5):663-665
106. Lucy Raymond F, Whittaker J, Jenkins L, Lench N, Chitty LS (2010) Molecular prenatal diagnosis: The impact of modern technologies. Prenat Diagn 30(7):674-681
107. Robin NH (2011) Dysmorphology in the era of whole exome sequencing. Curr Opin Pediatr 23(6):579-580
108. Yngvadottir B, MacArthur D, Jin H, Tyler-Smith C (2009) The promise and reality of personal genomics. Genome Biol 10(9):237
109. Lam HYK, Clark MJ, Chen R, Chen R, Natsoulis G, O'Huallachain M et al (2011) Performance comparison of whole-genome sequencing platforms. Nat Biotechnol 30 (1):78-82
110. Greenberg CR, Dilling LA, Thompson GR, Seargeant LE, Haworth JC, Phillips S et al (2009) The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations. Mol Genet Metab 96(4):201-207
111. Collins SA, Sinclair G, McIntosh S, Bamforth F, Thompson R, Sobol I et al (2010) Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut. Mol Genet Metab 101(2-3):200-204
112. Bick D, Dimmock D (2011) Whole exome and whole genome sequencing. Curr Opin Pediatr 23(6):594-600
113. Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA et al (2011) A timely arrival for genomic medicine. Genet Med 13(3):195-196
114. Andrew BS (2011) Exome sequencing: A transformative technology. Lancet Neurol 10 (10):942-946
115. Teer JK, Mullikin JC (2010) Exome sequencing: The sweet spot before whole genomes. Hum Mol Genet 19(R2):R145-R151
116. Jackson L, Pyeritz RE (2011) Molecular technologies open new clinical genetic vistas. Sci Transl Med 3(65):65ps2